Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUBLOK) | SANOFI PASTEUR | UNK | TFAA2410 | OT / LA |
patient was administered with an expired FLUBLOK today, with no reported adverse event; Initial information received on 02-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 31 years old male patient who was administered with an expired influenza trivalent recombinant vaccine [flublok] today, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Jun-2025, the patient received a dose of 0.5 ml of expired suspect influenza trivalent recombinant vaccine, Solution for injection (lot TFAA2410 and expiry date 30-May-2025) (strength: standard and frequency: once) via intramuscular route in the left deltoid for immunization today with no reported adverse event (expired product administered) (Latency : same day) Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.